Literature DB >> 20298709

Cr(VI) induces mitochondrial-mediated and caspase-dependent apoptosis through reactive oxygen species-mediated p53 activation in JB6 Cl41 cells.

Young-Ok Son1, J Andrew Hitron, Xin Wang, Qingshan Chang, Jingju Pan, Zhuo Zhang, Jiankang Liu, Shuxia Wang, Jeong-Chae Lee, Xianglin Shi.   

Abstract

Cr(VI) compounds are known to cause serious toxic and carcinogenic effects. Cr(VI) exposure can lead to a severe damage to the skin, but the mechanisms involved in the Cr(VI)-mediated toxicity in the skin are unclear. The present study examined whether Cr(VI) induces cell death by apoptosis or necrosis using mouse skin epidermal cell line, JB6 Cl41 cells. We also investigated the cellular mechanisms of Cr(VI)-induced cell death. This study showed that Cr(VI) induced apoptotic cell death in a dose-dependent manner, as demonstrated by the appearance of cell shrinkage, the migration of cells into the sub-G1 phase, the increase of Annexin V positively stained cells, and the formation of nuclear DNA ladders. Cr(VI) treatment resulted in the increases of mitochondrial membrane depolarization and caspases activation. Electron spin resonance (ESR) and fluorescence analysis revealed that Cr(VI) increased intracellular levels of reactive oxygen species (ROS) such as hydrogen peroxide and superoxide anion radical in dose-dependent manner. Blockage of p53 by si-RNA transfection suppressed mitochondrial changes of Bcl-2 family composition, mitochondrial membrane depolarization, caspase activation and PARP cleavage, leading to the inhibition of Cr(VI)-induced apoptosis. Further, catalase treatment prevented p53 phosphorylation stimulated by Cr(VI) with the concomitant inhibition of caspase activation. These results suggest that Cr(VI) induced a mitochondrial-mediated and caspase-dependent apoptosis in skin epidermal cells through activation of p53, which are mainly mediated by reactive oxidants generated by the chemical. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20298709      PMCID: PMC5051966          DOI: 10.1016/j.taap.2010.03.004

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  68 in total

1.  Involvement of caspase activation and mitochondrial stress in trichostatin A-induced apoptosis of Burkitt's lymphoma cell line, Akata.

Authors:  Young-Ok Son; Ki-Choon Choi; Jeong-Chae Lee; Sung-Ho Kook; Hyun-Jeong Lee; Young-Mi Jeon; Jong-Ghee Kim; Ju Kim; Won-Keun Lee; Yong-Suk Jang
Journal:  J Cell Biochem       Date:  2006-12-01       Impact factor: 4.429

2.  A model for p53-induced apoptosis.

Authors:  K Polyak; Y Xia; J L Zweier; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1997-09-18       Impact factor: 49.962

3.  A role of the Ca2+/Mg2+-dependent endonuclease in apoptosis and its inhibition by Poly(ADP-ribose) polymerase.

Authors:  A G Yakovlev; G Wang; B A Stoica; H A Boulares; A Y Spoonde; K Yoshihara; M E Smulson
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

4.  Induction of DNA-strand breaks in human peripheral blood lymphocytes and A549 lung cells by sodium dichromate: association with 8-oxo-2-deoxyguanosine formation and inter-individual variability.

Authors:  N J Hodges; B Adám; A J Lee; H J Cross; J K Chipman
Journal:  Mutagenesis       Date:  2001-11       Impact factor: 3.000

5.  Cyclosporin A inhibits chromium(VI)-induced apoptosis and mitochondrial cytochrome c release and restores clonogenic survival in CHO cells.

Authors:  D E Pritchard; J Singh; D L Carlisle; S R Patierno
Journal:  Carcinogenesis       Date:  2000-11       Impact factor: 4.944

6.  Critical role of poly(ADP-ribose) polymerase-1 in modulating the mode of cell death caused by continuous oxidative stress.

Authors:  Young-Ok Son; Sung-Ho Kook; Yong-Suk Jang; Xianglin Shi; Jeong-Chae Lee
Journal:  J Cell Biochem       Date:  2009-11-01       Impact factor: 4.429

7.  Chromium content of lungs of chromate workers with lung cancer.

Authors:  Y Tsuneta; Y Ohsaki; K Kimura; H Mikami; S Abe; M Murao
Journal:  Thorax       Date:  1980-04       Impact factor: 9.139

Review 8.  Dermatological toxicity of hexavalent chromium.

Authors:  Susan R Shelnutt; Phillip Goad; Donald V Belsito
Journal:  Crit Rev Toxicol       Date:  2007-06       Impact factor: 5.635

9.  Signal transduction of p53-independent apoptotic pathway induced by hexavalent chromium in U937 cells.

Authors:  Yoko Hayashi; Takashi Kondo; Qing-Li Zhao; Ryohei Ogawa; Zheng-Guo Cui; Loreto B Feril; Hidetoyo Teranishi; Minoru Kasuya
Journal:  Toxicol Appl Pharmacol       Date:  2004-06-01       Impact factor: 4.219

10.  Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death.

Authors:  N Zamzami; P Marchetti; M Castedo; D Decaudin; A Macho; T Hirsch; S A Susin; P X Petit; B Mignotte; G Kroemer
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

View more
  26 in total

1.  The dual roles of c-Jun NH2-terminal kinase signaling in Cr(VI)-induced apoptosis in JB6 cells.

Authors:  Young-Ok Son; John Andrew Hitron; Senping Cheng; Amit Budhraja; Zhuo Zhang; Nancy Lan Guo; Jeong-Chae Lee; Xianglin Shi
Journal:  Toxicol Sci       Date:  2010-11-03       Impact factor: 4.849

2.  Roles of ROS, Nrf2, and autophagy in cadmium-carcinogenesis and its prevention by sulforaphane.

Authors:  Yuting Wang; Ardhendu Kumar Mandal; Young-Ok Son; Poyil Pratheeshkumar; James T F Wise; Lei Wang; Zhuo Zhang; Xianglin Shi; Zhimin Chen
Journal:  Toxicol Appl Pharmacol       Date:  2018-06-06       Impact factor: 4.219

3.  Environmental Presence of Hexavalent but Not Trivalent Chromium Causes Neurotoxicity in Exposed Drosophila melanogaster.

Authors:  Pallavi Singh; D Kar Chowdhuri
Journal:  Mol Neurobiol       Date:  2016-05-11       Impact factor: 5.590

4.  Verrucarin A alters cell-cycle regulatory proteins and induces apoptosis through reactive oxygen species-dependent p38MAPK activation in the human breast cancer cell line MCF-7.

Authors:  Kandasamy Palanivel; Veerasamy Kanimozhi; Balamuthu Kadalmani
Journal:  Tumour Biol       Date:  2014-07-16

5.  Phenolic fraction of tobacco smoke inhibits BPDE-induced apoptosis response and potentiates cell transformation: role of attenuation of p53 response.

Authors:  Jagat J Mukherjee; Subodh Kumar; Ronald Gocinski; Jacquan Williams
Journal:  Chem Res Toxicol       Date:  2011-04-20       Impact factor: 3.739

Review 6.  Mitochondria targeting by environmental stressors: Implications for redox cellular signaling.

Authors:  Chuck Blajszczak; Marcelo G Bonini
Journal:  Toxicology       Date:  2017-07-24       Impact factor: 4.221

7.  Acquisition of mitochondrial dysregulation and resistance to mitochondrial-mediated apoptosis after genotoxic insult in normal human fibroblasts: a possible model for early stage carcinogenesis.

Authors:  Kristen P Nickens; Ying Han; Harini Shandilya; Ashley Larrimore; Gary F Gerard; Eric Kaldjian; Steven R Patierno; Susan Ceryak
Journal:  Biochim Biophys Acta       Date:  2011-10-25

8.  Different roles of ROS and Nrf2 in Cr(VI)-induced inflammatory responses in normal and Cr(VI)-transformed cells.

Authors:  Ram Vinod Roy; Poyil Pratheeshkumar; Yong-Ok Son; Lei Wang; John Andrew Hitron; Sasidharan Padmaja Divya; Zhuo Zhang; Xianglin Shi
Journal:  Toxicol Appl Pharmacol       Date:  2016-07-26       Impact factor: 4.219

9.  Hexavalent chromium induces energy metabolism disturbance and p53-dependent cell cycle arrest via reactive oxygen species in L-02 hepatocytes.

Authors:  Fang Xiao; Xiaotao Feng; Ming Zeng; Lan Guan; Qingqing Hu; Caigao Zhong
Journal:  Mol Cell Biochem       Date:  2012-08-11       Impact factor: 3.396

10.  Reactive oxygen species mediate Cr(VI)-induced carcinogenesis through PI3K/AKT-dependent activation of GSK-3β/β-catenin signaling.

Authors:  Young-Ok Son; Poyil Pratheeshkumar; Lei Wang; Xin Wang; Jia Fan; Dong-Hern Kim; Ju-Yeon Lee; Zhuo Zhang; Jeong-Chae Lee; Xianglin Shi
Journal:  Toxicol Appl Pharmacol       Date:  2013-05-22       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.